100 related articles for article (PubMed ID: 23159401)
1. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
2. Gd-EOB-DTPA-enhanced MR guidance in thermal ablation of liver malignancies.
Rosenberg C; Jahn A; Pickartz T; Wahnschaffe U; Patrzyk M; Hosten N
PLoS One; 2014; 9(12):e109217. PubMed ID: 25541950
[TBL] [Abstract][Full Text] [Related]
3. Breath-hold High-resolution T1-weighted Gradient Echo Liver MR Imaging with Compressed Sensing Obtained during the Gadoxetic Acid-enhanced Hepatobiliary Phase: Image Quality and Lesion Visibility Compared with a Standard T1-weighted Sequence.
Ihara K; Onoda H; Tanabe M; Iida E; Ueda T; Kobayashi T; Higashi M; Nickel MD; Imai H; Ito K
Magn Reson Med Sci; 2024 Apr; 23(2):146-152. PubMed ID: 36740257
[TBL] [Abstract][Full Text] [Related]
4. Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
Plaikner M; Kremser C; Zoller H; Steurer M; Glodny B; Jaschke W; Henninger B
Eur Radiol; 2019 Feb; 29(2):829-837. PubMed ID: 30027410
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI?
Halskov S; Krenzien F; Segger L; Geisel D; Hamm B; Pelzer U; Ihlow J; Schöning W; Auer TA; Fehrenbach U
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610992
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.
Li J; Ye X; Wang J; Yuan G; He S
Medicine (Baltimore); 2022 Sep; 101(36):e30482. PubMed ID: 36086711
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.
Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Fujita N; Kubo Y; Aishima S; Shirabe K; Yoshiura T; Honda H
Diagn Interv Radiol; 2015; 21(2):96-104. PubMed ID: 25698097
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the projection onto convex sets (POCS) algorithm at Gd-EOB-DTPA-enhanced hepatobiliary-phase hepatic MRI.
Nakamura S; Nakaura T; Kidoh M; Awai K; Namimoto T; Yoshinaka I; Harada K; Yamashita Y
Springerplus; 2016; 5(1):1311. PubMed ID: 27547685
[TBL] [Abstract][Full Text] [Related]
9. Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and
Fabritius MP; Garlipp B; Öcal O; Puhr-Westerheide D; Amthauer H; Geyer T; Holzgreve A; Ricke J; Kupitz D; Grosser OS; Omari J; Pech M; Seidensticker M; Grawe F; Seidensticker R
Eur Radiol Exp; 2024 Jan; 8(1):15. PubMed ID: 38282160
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences.
Verloh N; Utpatel K; Zeman F; Fellner C; Schlitt HJ; Müller M; Stroszczynski C; Evert M; Wiggermann P; Haimerl M
Oncotarget; 2018 Nov; 9(91):36371-36378. PubMed ID: 30555635
[TBL] [Abstract][Full Text] [Related]
11. Deep learning-based image reconstruction for the multi-arterial phase images: improvement of the image quality to assess the small hypervascular hepatic tumor on gadoxetic acid-enhanced liver MRI.
Yun SM; Hong SB; Lee NK; Kim S; Ji YH; Seo HI; Park YM; Noh BG; Nickel MD
Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38512517
[TBL] [Abstract][Full Text] [Related]
12. Comparison study of the MRI shoulder PROPELLER technique with differential image quality by variation of shoulder coils.
Khairi M; Zakaria F; Supar R; Mohd Z
Med J Malaysia; 2024 Mar; 79(Suppl 1):74-81. PubMed ID: 38555889
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Intraductal MRI and T2 Mapping of Cholangiocarcinoma Using Catheter Coils.
Khuntikeo N; Titapun A; Chamadol N; Boonphongsathien W; Sa-Ngiamwibool P; Taylor-Robinson SD; Wadsworth CA; Zhang S; Kardoulaki EM; Syms RRA
Hepat Med; 2020; 12():107-114. PubMed ID: 32801954
[TBL] [Abstract][Full Text] [Related]
14. New understanding of hepatobiliary MRI.
Pastor CM; Vilgrain V
Nat Rev Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38565648
[No Abstract] [Full Text] [Related]
15. Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Wong TY; Sun J; Kawasaki R; Ruamviboonsuk P; Gupta N; Lansingh VC; Maia M; Mathenge W; Moreker S; Muqit MMK; Resnikoff S; Verdaguer J; Zhao P; Ferris F; Aiello LP; Taylor HR
Ophthalmology; 2018 Oct; 125(10):1608-1622. PubMed ID: 29776671
[TBL] [Abstract][Full Text] [Related]
16. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
Kim SH; Lee CH; Kim BH; Kim WB; Yeom SK; Kim KA; Park CM
J Comput Assist Tomogr; 2012; 36(6):704-9. PubMed ID: 23192208
[TBL] [Abstract][Full Text] [Related]
17. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Ramage JK; Donaghy A; Farrant JM; Iorns R; Williams R
Gastroenterology; 1995 Mar; 108(3):865-9. PubMed ID: 7875490
[TBL] [Abstract][Full Text] [Related]
18. Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis.
Zhang L; Chen J; Lai X; Zhang X; Xu J
Front Oncol; 2023; 13():1253873. PubMed ID: 38273849
[TBL] [Abstract][Full Text] [Related]
19. Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.
Ruff SM; Cloyd JM; Pawlik TM
Ann Surg Oncol; 2023 Dec; 30(13):7935-7949. PubMed ID: 37691030
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.
Gu HX; Huang XS; Xu JX; Zhu P; Xu JF; Fan SF
J Digit Imaging; 2023 Dec; 36(6):2554-2566. PubMed ID: 37578576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
